Stan Smith - Sep 30, 2023 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Stock symbol
MAIA
Transactions as of
Sep 30, 2023
Transactions value $
$0
Form type
4
Date filed
10/3/2023, 04:05 PM
Previous filing
Jul 5, 2023
Next filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +10.5K $0.00 10.5K Sep 30, 2023 Common Stock 10.5K $2.20 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on September 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
F2 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.